141 related articles for article (PubMed ID: 14745801)
1. Insights into the interactions between a drug and a membrane protein target by fluorine cross-polarization magic angle spinning NMR.
Boland MP; Middleton DA
Magn Reson Chem; 2004 Feb; 42(2):204-11. PubMed ID: 14745801
[TBL] [Abstract][Full Text] [Related]
2. Detection of nucleotide binding to Na,K-ATPase in an aqueous membrane suspension by 13C cross-polarization magic-angle spinning NMR spectroscopy.
Middleton DA; Jakobsen LO; Esmann M
FEBS Lett; 2006 Dec; 580(28-29):6685-9. PubMed ID: 17126327
[TBL] [Abstract][Full Text] [Related]
3. A model of reversible inhibitors in the gastric H+/K+-ATPase binding site determined by rotational echo double resonance NMR.
Watts JA; Watts A; Middleton DA
J Biol Chem; 2001 Nov; 276(46):43197-204. PubMed ID: 11479301
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.
Gedda K; Briving C; Svensson K; Maxvall I; Andersson K
Biochem Pharmacol; 2007 Jan; 73(2):198-205. PubMed ID: 17081503
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the activities and the oligomeric forms of pig gastric H/K-ATPase.
Abe K; Kaya S; Hayashi Y; Imagawa T; Kikumoto M; Oiwa K; Katoh T; Yazawa M; Taniguchi K
Biochemistry; 2003 Dec; 42(51):15132-8. PubMed ID: 14690423
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor and ion binding sites on the gastric H,K-ATPase.
Munson K; Garcia R; Sachs G
Biochemistry; 2005 Apr; 44(14):5267-84. PubMed ID: 15807521
[TBL] [Abstract][Full Text] [Related]
7. Cation binding in Na,K-ATPase, investigated by 205Tl solid-state NMR spectroscopy.
Jakobsen LO; Malmendal A; Nielsen NC; Esmann M
Biochemistry; 2006 Sep; 45(35):10768-76. PubMed ID: 16939229
[TBL] [Abstract][Full Text] [Related]
8. Ligand docking in the gastric H+/K+-ATPase: homology modeling of reversible inhibitor binding sites.
Kim CG; Watts JA; Watts A
J Med Chem; 2005 Nov; 48(23):7145-52. PubMed ID: 16279772
[TBL] [Abstract][Full Text] [Related]
9. A K+ competitive, conformational probe of the H,K-ATPase.
Rabon EC; Sachs G; Leach CA; Keeling D
Acta Physiol Scand Suppl; 1992; 607():269-73. PubMed ID: 1333158
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of (H+ + K+)-ATPase and H+ accumulation in hog gastric membranes by trifluoperazine, verapamil and 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate.
Im WB; Blakeman DP; Mendlein J; Sachs G
Biochim Biophys Acta; 1984 Feb; 770(1):65-72. PubMed ID: 6320882
[TBL] [Abstract][Full Text] [Related]
11. Solid-state NMR measurements of the kinetics of the interaction between phospholamban and Ca2+-ATPase in lipid bilayers.
Hughes E; Middleton DA
Mol Membr Biol; 2005; 22(4):353-61. PubMed ID: 16154906
[TBL] [Abstract][Full Text] [Related]
12. Probing the contacts of a low-affinity substrate with a membrane-embedded transport protein using 1H-13C cross-polarisation magic-angle spinning solid-state NMR.
Patching SG; Henderson PJ; Sharples DJ; Middleton DA
Mol Membr Biol; 2013 Mar; 30(2):129-37. PubMed ID: 23173920
[TBL] [Abstract][Full Text] [Related]
13. Prevention and recovery of (mu(3)-diethylentriamino)-chloro-palladium(II)-chloride induced inhibition of Na/K-ATPase by SH containing ligands--L-cysteine and glutathione.
Krinulović K; Bugarcić Z; Vrvić M; Krstić D; Vasić V
Toxicol In Vitro; 2006 Dec; 20(8):1292-9. PubMed ID: 16697549
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gastric H+, K+-ATPase by 3-amino-5-methyl-2-(2-methyl-3-thienyl)imidazo[1,2-a]thieno[3,2-c]pyrid ine, SPI-447.
Ushiro T; Tsukimi Y; Tanaka H
Jpn J Pharmacol; 1997 Nov; 75(3):303-6. PubMed ID: 9434264
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional (type I) microcrystals of detergent-solubilized membrane-bound gastric (H+, K+)-ATPase enzyme from hog and rabbit stomachs.
Varga S
Acta Physiol Hung; 1994; 82(4):365-76. PubMed ID: 7785447
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cross-polarization dynamics between two abundant nuclei, (19)F and (1)H, based on spin thermodynamics theory.
Ando S; Harris RK; Reinsberg SA
J Magn Reson; 1999 Nov; 141(1):91-103. PubMed ID: 10527747
[TBL] [Abstract][Full Text] [Related]
17. Gastric H-K-ATPase and acid-resistant surface proteins.
Thangarajah H; Wong A; Chow DC; Crothers JM; Forte JG
Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G953-61. PubMed ID: 12016120
[TBL] [Abstract][Full Text] [Related]
18. Site-directed mutagenesis of cation coordinating residues in the gastric H,K-ATPase.
Rulli SJ; Louneva NM; Skripnikova EV; Rabon EC
Arch Biochem Biophys; 2001 Mar; 387(1):27-34. PubMed ID: 11368180
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
20. Probing the oligomeric state of phospholamban variants in phospholipid bilayers from solid-state NMR measurements of rotational diffusion rates.
Hughes E; Clayton JC; Middleton DA
Biochemistry; 2005 Mar; 44(10):4055-66. PubMed ID: 15751982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
